Zhang W, Shi S, Hong Y. Comment on ''patient preferences for CDK4/6 inhibitor treatments in HR + /HER2- early breast cancer: a discrete choice survey study''. Breast Cancer Res Treat 2025 Mar 27. doi: 10.1007/s10549-025-07673.
PMID: 40148705